"たけだP" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonShould Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? - Yahoo Finance
Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock? Yahoo Finance
Protagonist-Takeda, Novartis post phase III wins - BioWorld MedTech
Protagonist-Takeda, Novartis post phase III wins BioWorld MedTech
How This Takeda Technology Exec Is Embracing The Possibilities 04/24/2025 - MediaPost
How This Takeda Technology Exec Is Embracing The Possibilities 04/24/2025 MediaPost
Takeda and Okayama lead Japanese surge at Women's Open Championship - news.cgtn.com
Takeda and Okayama lead Japanese surge at Women's Open Championship news.cgtn.com
Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle - korea...
Takeda’s market exit and return of vonoprazan raise stakes in Korea’s drug pricing battle koreabiomed.com
Takeda PH promotes equitable access to medicines at SEA Summit - Philippine News Agency
Takeda PH promotes equitable access to medicines at SEA Summit Philippine News Agency
Takeda’s TAK-861 Shows Promise in Improving Wakefulness in Phase 1 Trial Among Healthy Men - Neur...
Takeda’s TAK-861 Shows Promise in Improving Wakefulness in Phase 1 Trial Among Healthy Men Neurology Live
Iclusig comes too late to rescue Takeda | ApexOnco - Clinical Trials news and analysis - Oncology...
Iclusig comes too late to rescue Takeda | ApexOnco - Clinical Trials news and analysis Oncology Pipeline
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on t...
Takeda-backed Poseida puts off-the-shelf CAR-T in its basket, places autologous therapy back on the shelf Fierce Biotech
Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company - koreabiome...
Takeda taps Julie Kim as next CEO, 1st Korean American to lead global pharma company koreabiomed.com
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures - BioSpace
Takeda’s Epilepsy Drug Stumbles in Back-to-Back Phase III Rare Disease Failures BioSpace
Scoop: San Diego Biotech Partners with Takeda, Lands $1.2B Milestone Deal - Fred Grier | Substack
Scoop: San Diego Biotech Partners with Takeda, Lands $1.2B Milestone Deal Fred Grier | Substack
Takeda Announces Phase 3 Topline Results for Soticlestat (TAK-935) in Patients with Dravet Syndro...
Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data - Fi...
Takeda's Poseida partnership starts to pay off with promising hemophilia A gene therapy data Fierce Biotech
Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now? - Yahoo Finance
Is Takeda Pharmaceutical Co. (TAK) Stock Undervalued Right Now? Yahoo Finance
Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide ...
Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti - koreabi...
Korean pharmas race for generic P-CAB market amid Takeda's uncertain future for Vocinti koreabiomed.com
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data d...
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail Fierce Biotech
Takeda’s narcolepsy blockbuster hopeful secures double phase 3 wins, teeing up FDA filing - Fierc...
Takeda’s narcolepsy blockbuster hopeful secures double phase 3 wins, teeing up FDA filing Fierce Biotech
Tau Propagation as a Diagnostic and Therapeutic Target for Dementia: Potentials and Unanswered Qu...
Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dre...
Takeda powers toward pivotal trials after phase 2b narcolepsy win but pauses multi-indication dream Fierce Biotech
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris - The Motley Fool
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris The Motley Fool
Takeda broadens gene therapy scope, turns to Poseida for non-viral approach - MedCity News
Takeda broadens gene therapy scope, turns to Poseida for non-viral approach MedCity News
Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologi...
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another - BioSpace
Takeda Pushes One Narcolepsy Program into Phase III, Discontinues Another BioSpace
Jeil Pharm's Jaqbo falls short in Korea’s booming P-CAB market with weak 1st-month sales - koreab...
Jeil Pharm's Jaqbo falls short in Korea’s booming P-CAB market with weak 1st-month sales koreabiomed.com
Host–microbiota interactions in rheumatoid arthritis - Nature
Takeda’s First-in-Class Orexin Agonist Oveporexton Posts Stellar Phase III Results - PharmiWeb.com
Takeda’s First-in-Class Orexin Agonist Oveporexton Posts Stellar Phase III Results PharmiWeb.com
Zydus inks licensing pact with Takeda to sell GERD drug - The Economic Times
Zydus inks licensing pact with Takeda to sell GERD drug The Economic Times
Torrent Pharma in pact with Takeda to commercialize acid reflux drug - livemint.com
Torrent Pharma in pact with Takeda to commercialize acid reflux drug livemint.com
Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Can...
Fabrication of Ultra-Thin Printed Organic TFT CMOS Logic Circuits Optimized for Low-Voltage Weara...
Zydus ties with Takeda to sell GERD drug - livemint.com
Zydus ties with Takeda to sell GERD drug livemint.com
Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in India - The Eco...
Mankind Pharma in licensing pact with Takeda to market acidity drug Vonoprazan in India The Economic Times
Torrent pharma enters into non - exclusive patent licensing agreement with Takeda Pharma - Expres...
Torrent pharma enters into non - exclusive patent licensing agreement with Takeda Pharma Express Pharma
Torrent ties up with Takeda for gastro drug - The Times of India
Torrent ties up with Takeda for gastro drug The Times of India
Otsuka Pharmaceutical Co., Ltd. - otsuka.co.jp
Otsuka Pharmaceutical Co., Ltd. otsuka.co.jp
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India - ET HealthWorld
Mankind Pharma inks pact with Takeda to commercialise Vonoprazan in India ET HealthWorld
TAKECAB® Now Available for the Treatment of Acid-related Diseases in Japan - otsuka.co.jp
TAKECAB® Now Available for the Treatment of Acid-related Diseases in Japan otsuka.co.jp
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India - Business Standard
Mankind Pharma inks pact with Takeda to commercialise acidity drug in India Business Standard
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India - Business Standard
Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India Business Standard
Torrent pharma inks licensing pact with Takeda to commercialise GERD drug - Zee Business
Torrent pharma inks licensing pact with Takeda to commercialise GERD drug Zee Business
Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in Indi...
Mankind Pharma signs agreement with Takeda to commercialise novel drug for GERD treatment in India financialexpress.com
226% return in 2 years: Zydus Lifesciences shares in focus as company inks licensing pact with Ta...
226% return in 2 years: Zydus Lifesciences shares in focus as company inks licensing pact with Takeda Zee Business
Memories of Nakajima Honmachi, Part 1: Ten loved ones lost to the atomic bombing - 中国新聞ヒロシ...
Memories of Nakajima Honmachi, Part 1: Ten loved ones lost to the atomic bombing 中国新聞ヒロシマ平和メディアセンター